Search
for
Sort by
Research 91–120 of 1000+
- Primary Care of Adult Women
- Evaluation and Management of the Hair Loss Patient in the Primary Care Setting
- Allergen‐specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient
- Alopecia Areata and Alopecia Areata Incognita
- New treatment modalities of alopecia areata
- Alopecia Areata
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Alopecia Areata: Current Review
- Treatment of Hair Loss
- Current and future pharmacotherapy for alopecia areata
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Hair follicles, their disorders and their opportunities
- Immune cell regulation of the hair cycle
- Nanomedicine-based immunotherapy for tissue regeneration
- SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report
- Alopecia Areata
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Management of autoimmune associated alopecia areata
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Nails and hair
- Principles of Therapy of Skin Diseases
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- 440 Squaric acid dibutylester, used in alopecia areata immunotherapy, promotes innate immune-driven hair growth with CD206+ macrophage accumulation in the dermis
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- 965 The importance of CD206+ macrophages in squaric acid dibutylester-induced hair cycle activation
- Vitiligo after Diphencyprone for Alopecia Areata
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Treatment of Alopecia Areata With Topical Sensitizers